表紙:キャリアスクリーニングの市場シェア、規模、動向、業界分析:タイプ別(拡張キャリアスクリーニング、標的疾患キャリアスクリーニング)、病状別、技術別、エンドユーザー別、地域別、セグメント予測(2022年~2030年)
市場調査レポート
商品コード
1078372

キャリアスクリーニングの市場シェア、規模、動向、業界分析:タイプ別(拡張キャリアスクリーニング、標的疾患キャリアスクリーニング)、病状別、技術別、エンドユーザー別、地域別、セグメント予測(2022年~2030年)

Carrier Screening Market Share, Size, Trends, Industry Analysis Report, By Type (Expanded Carrier Screening, Targeted Disease Carrier Screening); By Medical Condition; By Technology; By End-User; By Regions; Segment Forecast, 2022 - 2030

出版日: | 発行: Polaris Market Research | ページ情報: 英文 114 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
キャリアスクリーニングの市場シェア、規模、動向、業界分析:タイプ別(拡張キャリアスクリーニング、標的疾患キャリアスクリーニング)、病状別、技術別、エンドユーザー別、地域別、セグメント予測(2022年~2030年)
出版日: 2022年04月16日
発行: Polaris Market Research
ページ情報: 英文 114 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のキャリアスクリーニングの市場規模は、2030年までに36億4,000万米ドルに達すると予測されています。

当レポートでは、世界のキャリアスクリーニング市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、COVID-19の影響、タイプ別・病状別・技術別・エンドユーザー別・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 イントロダクション

  • レポートの説明
    • 調査の目的
    • 市場範囲
    • 前提条件
  • 利害関係者

第2章 エグゼクティブサマリー

  • 市場のハイライト

第3章 調査手法

  • 概要
    • データマイニング
  • データソース
    • 一次資料
    • 二次資料

第4章 世界のキャリアスクリーニング市場の洞察

  • 業界スナップショット
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターのファイブフォース分析
    • 供給企業の交渉力(中)
    • 新規参入者の脅威(低)
    • 買い手の交渉力(中)
    • 代替の脅威(中)
    • 既存企業間の競争(高)
  • PESTLE分析
  • 業界の動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のキャリアスクリーニング市場:病状別

  • 主な調査結果
  • イントロダクション
    • 病状別(2018年~2030年)
  • 肺疾患
    • 肺疾患別、地域別(2018年~2030年)
  • 血液疾患
    • 血液疾患別、地域別(2018年~2030年)
  • 神経疾患
    • 神経疾患別、地域別(2018年~2030年)
  • その他の疾患
    • その他の疾患別、地域別(2018年~2030年)

第6章 世界のキャリアスクリーニング市場:タイプ別

  • 主な調査結果
  • イントロダクション
    • タイプ別(2018年~2030年)
  • 拡張
    • 拡張別、地域別(2018年~2030年)
    • カスタマイズ型パネルテスト
    • 事前設計型パネルテスト
  • 標的疾患
    • 標的疾患別、地域別(2018年~2030年)

第7章 世界のキャリアスクリーニング市場:技術別

  • 主な調査結果
  • イントロダクション
    • 技術別(2018年~2030年)
  • DNAシーケンシング
    • DNAシーケンシング別、地域別(2018年~2030年)
  • ポリメラーゼ連鎖反応
    • ポリメラーゼ連鎖反応別、地域別(2018年~2030年)
  • マイクロアレイ
    • マイクロアレイ別、地域別(2018年~2030年)
  • その他の技術
    • その他の技術別、地域別(2018年~2030年)

第8章 世界のキャリアスクリーニング市場:エンドユーザー別

  • 主な調査結果
  • イントロダクション
    • エンドユーザー別(2018年~2030年)
  • 病院
    • 病院別、地域別(2018年~2030年)
  • リファレンスラボラトリーズ
    • リファレンスラボラトリーズ別、地域別(2018年~2030年)
  • 診療所・クリニック
    • 診療所・クリニック別、地域別(2018年~2030年)
  • その他のエンドユーザー
    • その他のエンドユーザー別、地域別(2018年~2030年)

第9章 世界のキャリアスクリーニング市場:地域別

  • 主な調査結果
  • イントロダクション
    • 市場評価:地域別(2018年~2030年)
  • 北米
    • 病状別(2018年~2030年)
    • エンドユーザー別(2018年~2030年)
    • タイプ別(2018年~2030年)
    • 技術別(2018年~2030年)
    • 米国
    • カナダ
  • 欧州
    • 病状別(2018年~2030年)
    • エンドユーザー別(2018年~2030年)
    • タイプ別(2018年~2030年)
    • 技術別(2018年~2030年)
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • オーストリア
  • アジア太平洋
    • 病状別(2018年~2030年)
    • エンドユーザー別(2018年~2030年)
    • タイプ別(2018年~2030年)
    • 技術別(2018年~2030年)
    • 中国
    • インド
    • 日本
    • マレーシア
    • インドネシア
    • 韓国
  • 中東・アフリカ
    • 病状別(2018年~2030年)
    • エンドユーザー別(2018年~2030年)
    • タイプ別(2018年~2030年)
    • 技術別(2018年~2030年)
    • サウジアラビア
    • 南アフリカ
    • イスラエル
    • アラブ首長国連邦
  • ラテンアメリカ
    • 病状別(2018年~2030年)
    • エンドユーザー別(2018年~2030年)
    • タイプ別(2018年~2030年)
    • 技術別(2018年~2030年)
    • メキシコ
    • ブラジル
    • アルゼンチン

第10章 競合情勢

  • 事業拡張・企業買収の分析
    • 事業拡張
    • 企業買収
  • パートナーシップ/コラボレーション/契約/展示会

第11章 企業プロファイル

  • 23Andme Inc.
  • Abbott Laboratories
  • Autogenomics Inc.
  • Danaher Corporation
  • Eurofins Scientific
  • Fulgent Genetics Inc.
  • Illumina Inc.
  • Invitae Corporation
  • Luminex Corporation
  • MedGenome
  • Myriad Genetics
  • Natera Inc.
  • Opko Health
  • Quest Diagnostics Incorporated
  • Roche AG
  • Sequenom Inc.
  • Thermo Fisher Scientific Inc.
  • True Health
図表

List of Tables

  • Table 1 Global Carrier Screening Market, by Medical Condition, by Region, 2018 - 2030 (USD Billion)
  • Table 2 Global Carrier Screening Market, by Type, by Region, 2018 - 2030 (USD Billion)
  • Table 3 Global Carrier Screening Market, by Technology, by Region, 2018 - 2030 (USD Billion)
  • Table 4 Global Carrier Screening Market, by End-User, by Region, 2018 - 2030 (USD Billion)
  • Table 5 Carrier Screening Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • Table 6 North America: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 7 North America: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 8 North America: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 9 North America: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 10 U.S.: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 11 U.S.: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 12 U.S.: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 13 U.S.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 14 Canada: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 15 Canada: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 16 Canada: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 17 Canada: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 18 Europe: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 19 Europe: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 20 Europe: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 21 Europe: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 22 Germany: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 23 Germany: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 24 Germany: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 25 Germany: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 26 France: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 27 France: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 28 France: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 29 France: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 30 UK: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 31 UK: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 32 UK: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 33 UK: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 34 Italy: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 35 Italy: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 36 Italy: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 37 Italy: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 38 Netherlands: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 39 Netherlands: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 40 Netherlands: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 41 Netherlands: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 42 Spain: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 43 Spain: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 44 Spain: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 45 Spain: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 46 Austria: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 47 Austria: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 48 Austria: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 49 Austria: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 50 Asia Pacific: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 51 Asia Pacific: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 52 Asia Pacific: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 53 Asia Pacific: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 54 China: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 55 China: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 56 China: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 57 China: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 58 Japan: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 59 Japan: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 60 Japan: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 61 Japan: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 62 India: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 63 India: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 64 India: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 65 India: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 66 Indonesia: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 67 Indonesia: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 68 Indonesia: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 69 Indonesia: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 70 Malaysia: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 71 Malaysia: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 72 Malaysia: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 73 Malaysia: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 74 South Korea: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 75 South Korea: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 76 South Korea: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 77 South Korea: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 78 Latin America: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 79 Latin America: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 80 Latin America: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 81 Latin America: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 82 Brazil: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 83 Brazil: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 84 Brazil: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 85 Brazil: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 86 Mexico: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 87 Mexico: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 88 Mexico: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 89 Mexico: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 90 Argentina: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 91 Argentina: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 92 Argentina: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 93 Argentina: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 94 Middle East & Africa: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 95 Middle East & Africa: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 96 Middle East & Africa: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 97 Middle East & Africa: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 98 UAE: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 99 UAE: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 100 UAE: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 101 UAE: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 102 Saudi Arabia: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 103 Saudi Arabia: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 104 Saudi Arabia: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 105 Saudi Arabia: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 106 South Africa: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 107 South Africa: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 108 South Africa: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 109 South Africa: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • Table 110 Israel: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • Table 111 Israel: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • Table 112 Israel: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 113 Israel: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)

List of Figures

  • Figure 1. Global Carrier Screening Market, 2018 - 2030 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up End-User
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Medical Condition
  • Figure 7. Global Carrier Screening Market, by Medical Condition, 2021 & 2030 (USD Billion)
  • Figure 8. Market by End-User
  • Figure 9. Global Carrier Screening Market, by End-User, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Type
  • Figure 11. Global Carrier Screening Market, by Type, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Technology
  • Figure 13. Global Carrier Screening Market, by Technology, 2021 & 2030 (USD Billion)
  • Figure 14. Carrier Screening Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • Figure 15. Strategic Analysis - Carrier Screening Market
目次
Product Code: PM2300

The global carrier screening market size is expected to reach USD 3.64 billion by 2030, according to a new study by Polaris Market Research. The report "Carrier Screening Market Share, Size, Trends, Industry Analysis Report, By Type (Expanded Carrier Screening, Targeted Disease Carrier Screening); By Medical Condition; By Technology; By End-User; By Regions; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The well-established healthcare infrastructure and the rise in innovative product introductions are driving the expansion of the industry. Many countries concentrate their efforts on developing enhanced medical infrastructure that includes enhanced treatment techniques.

Furthermore, developed-country nations have modern healthcare infrastructure integrated with various transmission methods, pushing the rise and need for these techniques throughout such countries. Many people wish to discover if their genetic or inherited disorders might be transmitted to their offerings. As a result, these factors are expected to open up promising growth opportunities for companies in the overall industry during the forecasted period.

Additionally, the increasing prevalence of fetal chromosomal abnormalities boosts industry growth. According to the WHO, congenital abnormalities are major causes of fetal and infant mortality, chronic illness, and disabilities. Every year, an estimated 295 000 newborns nationwide die within 28 days of birth due to congenital abnormalities. Thus, the rising prevalence of fetal abnormalities, increasing product launches, and established healthcare infrastructure propel the industry growth during the forecast period.

Based on the type, the expanded segment accounted for the leading share in the industry in 2021. Customized panel testing and predesigned panel testing are the extended segment components. Due to advancements in DNA sequencing, polymerase chain reaction, metabolomics, and other technologies, the expanded sector accounted for most of the global market share in 2021.

Market players such as Abbott Laboratories, 23Andme Inc., Autogenomics Inc., Danaher Corporation, Fulgent Genetics Inc., Eurofins Scientific, Illumina Inc., Luminex Corporation, Invitae Corporation, MedGenome, Natera Inc., Myriad Genetics, Opko Health, Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc., Roche AG, Sequenom Inc., and True Health. are some key players operating in the global market.

Polaris Market Research has segmented the carrier screening market report based on type, medical condition, technology, end-user, and region:

Carrier Screening, Type Outlook (Revenue - USD Billion, 2018 - 2030)

Expanded

Customized Panel Testing

Predesigned Panel Testing

Targeted Disease

Carrier Screening, Medical Condition Outlook (Revenue - USD Billion, 2018 - 2030)

Pulmonary Conditions

Hematological Conditions

Neurological Conditions

Other Conditions

Carrier Screening, Technology Outlook (Revenue - USD Billion, 2018 - 2030)

DNA Sequencing

Polymerase Chain Reaction

Microarrays

Other Technologies

Carrier Screening, End-User Outlook (Revenue - USD Billion, 2018 - 2030)

Hospitals

Reference Laboratories

Physician Offices & Clinics

Other End Users

Carrier Screening, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S.

Canada

Europe

France

Germany

UK

Italy

Netherlands

Spain

Austria

Asia Pacific

China

India

Japan

Malaysia

South Korea

Indonesia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Carrier Screening Market Insights

  • 4.1. Carrier Screening - Industry Snapshot
  • 4.2. Carrier Screening Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing emphasis on early disease detection & prevention
      • 4.2.1.2. Increasing awareness of carrier screening
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of service
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Carrier Screening Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Carrier Screening Market, by Medical Condition

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
  • 5.3. Pulmonary Conditions
    • 5.3.1. Global Carrier Screening Market, by Pulmonary Conditions, by Region, 2018 - 2030 (USD Billion)
  • 5.4. Hematological Conditions
    • 5.4.1. Global Carrier Screening Market, by Hematological Conditions, by Region, 2018 - 2030 (USD Billion)
  • 5.5. Neurological Conditions
    • 5.5.1. Global Carrier Screening Market, by Neurological Conditions, by Region, 2018 - 2030 (USD Billion)
  • 5.6. Other Conditions
    • 5.6.1. Global Carrier Screening Market, by Other Conditions, by Region, 2018 - 2030 (USD Billion)

6. Global Carrier Screening Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
  • 6.3. Expanded
    • 6.3.1. Global Carrier Screening Market, by Expanded, by Region, 2018 - 2030 (USD Billion)
    • 6.3.2. Customized Panel Testing
      • 6.3.2.1. Global Carrier Screening Market, by Customized Panel Testing, by Region, 2018 - 2030 (USD Billion)
    • 6.3.3. Predesigned Panel Testing
      • 6.3.3.1. Global Carrier Screening Market, by Predesigned Panel Testing, by Region, 2018 - 2030 (USD Billion)
  • 6.4. Targeted Disease
    • 6.4.1. Global Carrier Screening Market, by Targeted Disease, by Region, 2018 - 2030 (USD Billion)

7. Global Carrier Screening Market, by Technology

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • 7.3. DNA Sequencing
    • 7.3.1. Global Carrier Screening Market, by DNA Sequencing, by Region, 2018 - 2030 (USD Billion)
  • 7.4. Polymerase Chain Reaction
    • 7.4.1. Global Carrier Screening Market, by Polymerase Chain Reaction, by Region, 2018 - 2030 (USD Billion)
  • 7.5. Microarrays
    • 7.5.1. Global Carrier Screening Market, by Microarrays, by Region, 2018 - 2030 (USD Billion)
  • 7.6. Other Technologies
    • 7.6.1. Global Carrier Screening Market, by Other Technologies, by Region, 2018 - 2030 (USD Billion)

8. Global Carrier Screening Market, by End-User

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
  • 8.3. Hospitals
    • 8.3.1. Global Carrier Screening Market, by Hospitals, by Region, 2018 - 2030 (USD Billion)
  • 8.4. Reference Laboratories
    • 8.4.1. Global Carrier Screening Market, by Reference Laboratories, by Region, 2018 - 2030 (USD Billion)
  • 8.5. Physician Offices & Clinics
    • 8.5.1. Global Carrier Screening Market, by Physician Offices & Clinics, by Region, 2018 - 2030 (USD Billion)
  • 8.6. Other End Users
    • 8.6.1. Global Carrier Screening Market, by Other End Users, by Region, 2018 - 2030 (USD Billion)

9. Global Carrier Screening Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Carrier Screening Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • 9.3. Carrier Screening Market - North America
    • 9.3.1. North America: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
    • 9.3.2. North America: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
    • 9.3.3. North America: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
    • 9.3.4. North America: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.3.5. Carrier Screening Market - U.S.
      • 9.3.5.1. U.S.: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.3.5.2. U.S.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.3.5.3. U.S.: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.3.5.4. U.S.: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.3.6. Carrier Screening Market - Canada
      • 9.3.6.1. Canada: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.3.6.2. Canada: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.3.6.3. Canada: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.3.6.4. Canada: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.4. Carrier Screening Market - Europe
    • 9.4.1. Europe: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
    • 9.4.2. Europe: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
    • 9.4.3. Europe: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
    • 9.4.4. Europe: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.4.5. Carrier Screening Market - UK
      • 9.4.5.1. UK: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.4.5.2. UK: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.5.3. UK: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.4.5.4. UK: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.4.6. Carrier Screening Market - France
      • 9.4.6.1. France: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.4.6.2. France: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.6.3. France: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.4.6.4. France: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.4.7. Carrier Screening Market - Germany
      • 9.4.7.1. Germany: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.4.7.2. Germany: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.7.3. Germany: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.4.7.4. Germany: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.4.8. Carrier Screening Market - Italy
      • 9.4.8.1. Italy: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.4.8.2. Italy: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.8.3. Italy: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.4.8.4. Italy: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.4.9. Carrier Screening Market - Spain
      • 9.4.9.1. Spain: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.4.9.2. Spain: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.9.3. Spain: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.4.9.4. Spain: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.4.10. Carrier Screening Market - Netherlands
      • 9.4.10.1. Netherlands: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.4.10.2. Netherlands: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.10.3. Netherlands: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.4.10.4. Netherlands: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.4.11. Carrier Screening Market - Austria
      • 9.4.11.1. Austria: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.4.11.2. Austria.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.4.11.3. Austria: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.4.11.4. Austria: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.5. Carrier Screening Market - Asia Pacific
    • 9.5.1. Asia Pacific: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
    • 9.5.2. Asia Pacific: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
    • 9.5.3. Asia Pacific: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
    • 9.5.4. Asia Pacific: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.5.5. Carrier Screening Market - China
      • 9.5.5.1. China: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.5.5.2. China.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.5.5.3. China: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.5.5.4. China: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.5.6. Carrier Screening Market - India
      • 9.5.6.1. India: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.5.6.2. India.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.5.6.3. India: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.5.6.4. India: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.5.7. Carrier Screening Market - Japan
      • 9.5.7.1. Japan: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.5.7.2. Japan.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.5.7.3. Japan: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.5.7.4. Japan: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.5.8. Carrier Screening Market - Malaysia
      • 9.5.8.1. Malaysia: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.5.8.2. Malaysia.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.5.8.3. Malaysia: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.5.8.4. Malaysia: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.5.9. Carrier Screening Market - Indonesia
      • 9.5.9.1. Indonesia: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.5.9.2. Indonesia.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.5.9.3. Indonesia: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.5.9.4. Indonesia: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.5.10. Carrier Screening Market - South Korea
      • 9.5.10.1. South Korea: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.5.10.2. South Korea.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.5.10.3. South Korea: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.5.10.4. South Korea: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.6. Carrier Screening Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
    • 9.6.2. Middle East & Africa: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
    • 9.6.3. Middle East & Africa: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
    • 9.6.4. Middle East & Africa: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.6.5. Carrier Screening Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.6.6. Carrier Screening Market - South Africa
      • 9.6.6.1. South Africa: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.6.6.2. South Africa: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.6.6.3. South Africa: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.6.6.4. South Africa: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.6.7. Carrier Screening Market - Israel
      • 9.6.7.1. Israel: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.6.7.2. Israel: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.6.7.3. Israel: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.6.7.4. Israel: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.6.8. Carrier Screening Market - UAE
      • 9.6.8.1. UAE: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.6.8.2. UAE: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.6.8.3. UAE: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.6.8.4. UAE: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.7. Carrier Screening Market - Latin America
    • 9.7.1. Latin America: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
    • 9.7.2. Latin America: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
    • 9.7.3. Latin America: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
    • 9.7.4. Latin America: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.7.5. Carrier Screening Market - Mexico
      • 9.7.5.1. Mexico: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.7.5.2. Mexico: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.7.5.3. Mexico: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.7.5.4. Mexico: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.7.6. Carrier Screening Market - Brazil
      • 9.7.6.1. Brazil: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.7.6.2. Brazil: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.7.6.3. Brazil: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.7.6.4. Brazil: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
    • 9.7.7. Carrier Screening Market - Argentina
      • 9.7.7.1. Argentina: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
      • 9.7.7.2. Argentina: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
      • 9.7.7.3. Argentina: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
      • 9.7.7.4. Argentina: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. 23Andme Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Abbott Laboratories
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Autogenomics Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Danaher Corporation
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Eurofins Scientific
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Fulgent Genetics Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Illumina Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Invitae Corporation
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Luminex Corporation
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. MedGenome
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Myriad Genetics
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Natera Inc.
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Opko Health
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Quest Diagnostics Incorporated
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Roche AG
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development
  • 11.16. Sequenom Inc.
    • 11.16.1. Company Overview
    • 11.16.2. Financial Performance
    • 11.16.3. Product Benchmarking
    • 11.16.4. Recent Development
  • 11.17. Thermo Fisher Scientific Inc.
    • 11.17.1. Company Overview
    • 11.17.2. Financial Performance
    • 11.17.3. Product Benchmarking
    • 11.17.4. Recent Development
  • 11.18. True Health
    • 11.18.1. Company Overview
    • 11.18.2. Financial Performance
    • 11.18.3. Product Benchmarking
    • 11.18.4. Recent Development